Abstract
The emergence of a new infectious disease, AIDS, in the early 1980s resulted in the development of a national AIDS surveillance system. AIDS surveillance data provided an understanding of transmission risks and characterized communities affected by the epidemic. Later, these data provided the basis for allocating resources for prevention and treatment programs. New treatments have dramatically improved survival. Resulting declines in AIDS incidence and deaths offer hope that HIV disease can be successfully managed. However, to prevent and control HIV/AIDS in the coming decades, the public health community must address new challenges. These include the defining of the role of treatment in reducing infectiousness; the potential for an epidemic of treatment-resistant HIV; side effects of treatment; complacency that leads to relapses to high-risk behaviors; and inadequate surveillance and research capacity at state and local levels to guide the development of health interventions. Meeting these challenges will require reinvesting in the public health capacity of state and local health departments, restructuring HIV/AIDS surveillance programs to collect the data needed to guide the response to the epidemic, and providing timely answers to emerging epidemiologic questions.
Full Text
The Full Text of this article is available as a PDF (90.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bindman A. B., Osmond D., Hecht F. M., Lehman J. S., Vranizan K., Keane D., Reingold A. Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA. 1998 Oct 28;280(16):1416–1420. doi: 10.1001/jama.280.16.1416. [DOI] [PubMed] [Google Scholar]
- Birss R. R., Gibbs J. I., Wallis P. M. A cryostat for use with a torque magnetometer down to 4.2 degree K. J Sci Instrum. 1968 Jan;1(1):15–21. doi: 10.1088/0022-3735/1/1/303. [DOI] [PubMed] [Google Scholar]
- Blanche S., Tardieu M., Rustin P., Slama A., Barret B., Firtion G., Ciraru-Vigneron N., Lacroix C., Rouzioux C., Mandelbrot L. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999 Sep 25;354(9184):1084–1089. doi: 10.1016/S0140-6736(99)07219-0. [DOI] [PubMed] [Google Scholar]
- Fleming P. L., Ward J. W., Karon J. M., Hanson D. L., De Cock K. M. Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. AIDS. 1998;12 (Suppl A):S55–S61. [PubMed] [Google Scholar]
- Lindegren M. L., Byers R. H., Jr, Thomas P., Davis S. F., Caldwell B., Rogers M., Gwinn M., Ward J. W., Fleming P. L. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999 Aug 11;282(6):531–538. doi: 10.1001/jama.282.6.531. [DOI] [PubMed] [Google Scholar]
- Shaffer N., Chuachoowong R., Mock P. A., Bhadrakom C., Siriwasin W., Young N. L., Chotpitayasunondh T., Chearskul S., Roongpisuthipong A., Chinayon P. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999 Mar 6;353(9155):773–780. doi: 10.1016/s0140-6736(98)10411-7. [DOI] [PubMed] [Google Scholar]